Autopsy report · NCT01644097
Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy
Cause of deathFunding or business
“issues with obtaining study product”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Conditions
- Diarrhea; Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Lactobacillus plantarum strain 299v; Lactobacillus acidophilus probiotic; placebo; laboratory biomarker analysis; questionnaire administration; quality-of-life assessment
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Remote Trial - Tobacco Product Standard (VLNC)
“Study determined to be not feasible at this time due to limited availability of study product and limited availability of study products in the marketplace.” - Pain Sensitivity in NREM Parasomnia (NOCISOMNIE)
“Material needed for study was not available” - Continuous Data Collection and Analysis for Stroke Prevention Using a Wearable Sensor
“Unable to obtain equipment from Sponsor to be able to proceed with the study.” - Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
“Discontinuation of the study Product by manufacturer” - Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
“Study was unable to accrue subjects”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.